Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024
Compare Balance Sheet Results of Emmessar Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
5.84
-0.84
-14.38%
Share Warrants & Outstandings
Total Reserve
2.71
-5.14
7.85
152.72%
Shareholder's Funds
7.71
0.70
7.01
1,001.43%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
7.38
-7.38
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
7.38
-7.38
-100.00%
Deferred Tax Assets / Liabilities
0.32
-0.19
0.51
268.42%
Other Long Term Liabilities
0.59
0.00
0.59
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.13
0.00
0.13
0.00%
Total Non-Current Liabilities
1.04
7.20
-6.16
-85.56%
Current Liabilities
Trade Payables
0.00
0.24
-0.24
-100.00%
Other Current Liabilities
0.13
0.08
0.05
62.50%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.34
0.00
0.34
0.00%
Total Current Liabilities
0.47
0.33
0.14
42.42%
Total Liabilities
9.22
8.22
1.00
12.17%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.04
6.94
-4.90
-70.61%
Less: Accumulated Depreciation
0.82
2.27
-1.45
-63.88%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.22
4.67
-3.45
-73.88%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.59
0.00
0.59
0.00%
Long Term Loans & Advances
0.00
2.40
-2.40
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
1.81
7.07
-5.26
-74.40%
Current Assets Loans & Advances
Current Investments
0.01
0.00
0.01
0.00%
Inventories
0.12
0.21
-0.09
-42.86%
Sundry Debtors
0.02
0.00
0.02
0.00%
Cash and Bank
6.87
0.01
6.86
68,600.00%
Other Current Assets
0.09
0.00
0.09
0.00%
Short Term Loans and Advances
0.29
0.93
-0.64
-68.82%
Total Current Assets
7.41
1.15
6.26
544.35%
Net Current Assets (Including Current Investments)
6.93
0.83
6.10
734.94%
Total Current Assets Excluding Current Investments
7.40
1.15
6.25
543.48%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.22
8.22
1.00
12.17%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
7.38
-7.38
-100.00%
Book Value per share (adjusted)
15.43
1.20
14.23
1,185.83%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Annual - Investments
Investments 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Annual - Current Assets
Current Assets 7.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024






